Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Ischemic Postconditioning on Myocardial Function and Infarct Size Following Reperfusion Injury in Diabetic Rats Pretreated With Vildagliptin
Authors
Keywords
-
Journal
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
Volume 23, Issue 2, Pages 174-183
Publisher
SAGE Publications
Online
2017-09-13
DOI
10.1177/1074248417729881
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phosphorylation of GSK-3β and reduction of apoptosis as targets of troxerutin effect on reperfusion injury of diabetic myocardium
- (2015) Behnaz Mokhtari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Modeling type 2 diabetes in rats using high fat diet and streptozotocin
- (2014) Søs Skovsø Journal of Diabetes Investigation
- Vildagliptin Ameliorates Oxidative Stress and Pancreatic Beta Cell Destruction in Type 1 Diabetic Rats
- (2013) Danielle de Lima Ávila et al. ARCHIVES OF MEDICAL RESEARCH
- Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats
- (2013) Nattayaporn Apaijai et al. BRITISH JOURNAL OF PHARMACOLOGY
- Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats
- (2013) Hong Li et al. Cardiovascular Diabetology
- Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner
- (2013) Derek J Hausenloy et al. Cardiovascular Diabetology
- Hypercholesterolemia Abrogates the Cardioprotection of Ischemic Postconditioning in Isolated Rat Heart: Roles of Glycogen Synthase Kinase-3β and the Mitochondrial Permeability Transition Pore
- (2013) Nan Wu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Phosphodiesterase-5 inhibitor tadalafil attenuates oxidative stress and protects against myocardial ischemia/reperfusion injury in type 2 diabetic mice
- (2013) Saisudha Koka et al. FREE RADICAL BIOLOGY AND MEDICINE
- Profile of vildagliptin in type 2 diabetes: efficacy, safety, and patient acceptability
- (2013) Chang Yu Pan et al. Therapeutics and Clinical Risk Management
- Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning
- (2012) Takayuki Miki et al. Cardiovascular Diabetology
- Vildagliptin preserves the mass and function of pancreatic β cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes
- (2012) S. Hamamoto et al. DIABETES OBESITY & METABOLISM
- Chronic DPP-IV inhibition with PKF-275-055 attenuates inflammation and improves gene expressions responsible for insulin secretion in streptozotocin induced diabetic rats
- (2012) Atul Sureshrao Akarte et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia–reperfusion injury
- (2012) Kroekkiat Chinda et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Molecular and metabolic mechanisms of cardiac dysfunction in diabetes
- (2012) Chirag H. Mandavia et al. LIFE SCIENCES
- Early and late effects of the DPP-4 inhibitor vildagliptin in a rat model of post-myocardial infarction heart failure
- (2011) Meimei Yin et al. Cardiovascular Diabetology
- The Additive Effects of Ischemic Postconditioning and Cyclosporine-A on Nitric Oxide Activity and Functions of Diabetic Myocardium Injured by Ischemia/Reperfusion
- (2011) Reza Badalzadeh et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- The efficacy and safety of vildagliptin in patients with type 2 diabetes: a meta-analysis of randomized clinical trials
- (2011) L. Cai et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Cardioprotection with Postconditioning: Loss of Efficacy in Murine Models of Type-2 and Type-1 Diabetes
- (2010) Karin Przyklenk et al. ANTIOXIDANTS & REDOX SIGNALING
- Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunction
- (2009) Stuart A. Cook et al. EUROPEAN HEART JOURNAL
- Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
- (2009) Roger Yazbeck et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice
- (2008) Omar Bouhidel et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started